Foundation Medicine
@foundationmedicine.bsky.social
Foundation Medicine a precision medicine company transforming lives in cancer and beyond.
Community Guidelines: http://bit.ly/3iSL4jW
Community Guidelines: http://bit.ly/3iSL4jW
New #ProstateCancer research published in @CCR_AACR – “Additive clinical utility of microsatellite instability and tumor mutational burden to predict immune checkpoint inhibitor effectiveness in metastatic castration-resistant prostate cancer”: spkl.io/63320Acu2w
December 22, 2025 at 2:00 PM
New #ProstateCancer research published in @CCR_AACR – “Additive clinical utility of microsatellite instability and tumor mutational burden to predict immune checkpoint inhibitor effectiveness in metastatic castration-resistant prostate cancer”: spkl.io/63320Acu2w
#Research leveraged real-world data to evaluate changes in ctDNA tumor fraction & blood tumor mutational burden to assess treatment response to immune checkpoint inhibitors in a pan-tumor setting. Learn more: spkl.io/63328AcuwI
Behind the Manuscript: ctDNA monitoring & blood TMB in a pan-tumor setting
Learn more about how Foundation Medicine researchers and collaborators leveraged real-world data to evaluate changes in circulating tumor DNA (ctDNA) tumor fraction and blood tumor mutational burden to assess treatment response to immune checkpoint inhibitors in a pan-tumor setting.
Hear more from Candice Francheska Tambaoan, MPH, Data Scientist II at Foundation Medicine, on how this research shows the utility that ctDNA monitoring can have in assessing treatment response and serving as a complement to imaging.
spkl.io
December 18, 2025 at 8:00 PM
#Research leveraged real-world data to evaluate changes in ctDNA tumor fraction & blood tumor mutational burden to assess treatment response to immune checkpoint inhibitors in a pan-tumor setting. Learn more: spkl.io/63328AcuwI
Innovations in precision medicine require collaboration, actionable insights and a commitment to advancing cutting-edge science. Explore how we are helping our #biopharma partners turn scientific promise into progress in our new blog: spkl.io/63329AcBID
December 16, 2025 at 6:00 PM
Innovations in precision medicine require collaboration, actionable insights and a commitment to advancing cutting-edge science. Explore how we are helping our #biopharma partners turn scientific promise into progress in our new blog: spkl.io/63329AcBID
#DYK that MTAP loss reporting can vary across NGS vendors? In a study from Sarah Cannon Research Institute, Foundation Medicine’s tissue NGS detected MTAP loss in about 1 out of 10 solid tumors. It’s not a rare biomarker – even though it can be hard to identify accurately.
December 15, 2025 at 9:17 PM
#DYK that MTAP loss reporting can vary across NGS vendors? In a study from Sarah Cannon Research Institute, Foundation Medicine’s tissue NGS detected MTAP loss in about 1 out of 10 solid tumors. It’s not a rare biomarker – even though it can be hard to identify accurately.
Our team is excited to present two new pieces of research in #breastcancer that show the importance of robust homozygous gene loss reporting in BRCA1/2 and PTEN. Learn more from Foundation Medicine at #SABCS25 - booth 1342: spkl.io/63323A9iEF
December 10, 2025 at 4:00 PM
Our team is excited to present two new pieces of research in #breastcancer that show the importance of robust homozygous gene loss reporting in BRCA1/2 and PTEN. Learn more from Foundation Medicine at #SABCS25 - booth 1342: spkl.io/63323A9iEF
New #research in non-small cell lung cancer reflects a simulated, retrospective analysis of oncology biomarker assays. Read this publication in The Oncologist –spkl.io/63322A9Vdk
December 9, 2025 at 2:00 PM
New #research in non-small cell lung cancer reflects a simulated, retrospective analysis of oncology biomarker assays. Read this publication in The Oncologist –spkl.io/63322A9Vdk
Join us at #SABCS25, December 9-12. Visit booth 1342 to learn how Foundation Medicine’s comprehensive genomic testing portfolio can help inform treatment options for advanced breast cancer patients. Learn more: spkl.io/63325AgY6S
December 8, 2025 at 2:00 PM
Join us at #SABCS25, December 9-12. Visit booth 1342 to learn how Foundation Medicine’s comprehensive genomic testing portfolio can help inform treatment options for advanced breast cancer patients. Learn more: spkl.io/63325AgY6S
Join us at booth B111, hall 4 at #ESMOAsia25 for our final booth talks, including sessions around Foundation Medicine’s tissue-based RNA sequencing test, our clonal hematopoiesis algorithm and use cases around AI and precision medicine. Find out more: spkl.io/63320Agvl6
December 6, 2025 at 11:00 PM
Join us at booth B111, hall 4 at #ESMOAsia25 for our final booth talks, including sessions around Foundation Medicine’s tissue-based RNA sequencing test, our clonal hematopoiesis algorithm and use cases around AI and precision medicine. Find out more: spkl.io/63320Agvl6
Our #BoothTalks series are underway at #ESMOAsia25! Learn more about Saturday’s sessions below. Click here for more information: spkl.io/63320AgmGr
December 5, 2025 at 11:00 PM
Our #BoothTalks series are underway at #ESMOAsia25! Learn more about Saturday’s sessions below. Click here for more information: spkl.io/63320AgmGr
Announcement ‼️ – 100 approved companion diagnostic indications! Through this historic milestone, we are proud to reaffirm our commitment to transforming lives in cancer and beyond and continuing to help drive a new wave of precision medicine: spkl.io/63322AglR0
December 4, 2025 at 8:05 PM
Announcement ‼️ – 100 approved companion diagnostic indications! Through this historic milestone, we are proud to reaffirm our commitment to transforming lives in cancer and beyond and continuing to help drive a new wave of precision medicine: spkl.io/63322AglR0
Attending #ESMOAsia25? Join us tomorrow as we kick off our “Booth Talks” – booth B111, hall 4. Learn about Friday's programming below. Want to connect with our team? Find the full Booth Talks schedule and more information here: spkl.io/63323AgkSS
December 4, 2025 at 12:00 PM
Attending #ESMOAsia25? Join us tomorrow as we kick off our “Booth Talks” – booth B111, hall 4. Learn about Friday's programming below. Want to connect with our team? Find the full Booth Talks schedule and more information here: spkl.io/63323AgkSS
New publication – learn more about new research published in @plosone.org: “Analytical validation of a homologous recombination deficiency signature (HRDsig) in pan-tumor tissue samples.” Click here: spkl.io/63327AgprD
December 3, 2025 at 4:00 PM
New publication – learn more about new research published in @plosone.org: “Analytical validation of a homologous recombination deficiency signature (HRDsig) in pan-tumor tissue samples.” Click here: spkl.io/63327AgprD
Connect with Foundation Medicine at #ASH25! Interested in exploring how comprehensive genomic profiling can impact your work in #hematology? Visit booth 1816 or schedule a meeting with us to learn more about our hematologic profiling capabilities: spkl.io/63324AeLKA
December 1, 2025 at 2:00 PM
Connect with Foundation Medicine at #ASH25! Interested in exploring how comprehensive genomic profiling can impact your work in #hematology? Visit booth 1816 or schedule a meeting with us to learn more about our hematologic profiling capabilities: spkl.io/63324AeLKA
Join us for an industry satellite symposium at #ESMOAsia25 “From Insights to Outcomes: How Comprehensive Genomic Profiling Redefines Cancer Care.” Learn more below!
Connect with our team at this year’s meeting: spkl.io/63329AeIrU
Connect with our team at this year’s meeting: spkl.io/63329AeIrU
November 30, 2025 at 11:00 PM
Join us for an industry satellite symposium at #ESMOAsia25 “From Insights to Outcomes: How Comprehensive Genomic Profiling Redefines Cancer Care.” Learn more below!
Connect with our team at this year’s meeting: spkl.io/63329AeIrU
Connect with our team at this year’s meeting: spkl.io/63329AeIrU
At #ESMOAsia25, Foundation Medicine is excited to join industry peers from across the Asia-Pacific region to discuss the latest research & innovations happening in oncology. Visit Foundation Medicine at booth B111, hall 4 to meet with our team. Learn more: spkl.io/63327AeniJ
November 25, 2025 at 9:00 PM
At #ESMOAsia25, Foundation Medicine is excited to join industry peers from across the Asia-Pacific region to discuss the latest research & innovations happening in oncology. Visit Foundation Medicine at booth B111, hall 4 to meet with our team. Learn more: spkl.io/63327AeniJ
#NewResearch – “Intratumoral heterogeneity and immunotherapy resistance: clinical implications” Read more: spkl.io/63320AencI
November 25, 2025 at 1:00 PM
#NewResearch – “Intratumoral heterogeneity and immunotherapy resistance: clinical implications” Read more: spkl.io/63320AencI
A recently published investigator-initiated study utilized Foundation Medicine’s tissue- and blood-based comprehensive genomic profiling to identify actionable alterations: “Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial” in @natmed.nature.com
November 14, 2025 at 3:05 PM
A recently published investigator-initiated study utilized Foundation Medicine’s tissue- and blood-based comprehensive genomic profiling to identify actionable alterations: “Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial” in @natmed.nature.com
We are proud to support @lungevity.bsky.social's Cancer Precision Medicine Commons to further raise awareness and education around biomarker testing this #CancerBiomarkerDay. Click here for more information and resources: spkl.io/63321Abxmz
November 13, 2025 at 1:00 PM
We are proud to support @lungevity.bsky.social's Cancer Precision Medicine Commons to further raise awareness and education around biomarker testing this #CancerBiomarkerDay. Click here for more information and resources: spkl.io/63321Abxmz
Our latest webinar with @precmedonline.bsky.social will focus on the evolving landscape of biomarker-genomic treatment for advanced non-small cell #lungcancer (NSCLC). Join us for this expert-led conversation – register today: spkl.io/63320AwAb2
November 7, 2025 at 1:00 PM
Our latest webinar with @precmedonline.bsky.social will focus on the evolving landscape of biomarker-genomic treatment for advanced non-small cell #lungcancer (NSCLC). Join us for this expert-led conversation – register today: spkl.io/63320AwAb2
#NewResearch published in Cancer Research Communications: “Succinate dehydrogenase B (SDHB) overexpression with enzymatic dysfunction defines a distinct subtype of undifferentiated pleomorphic sarcoma.” Click to learn more: spkl.io/63327AwdBx
November 4, 2025 at 6:00 PM
#NewResearch published in Cancer Research Communications: “Succinate dehydrogenase B (SDHB) overexpression with enzymatic dysfunction defines a distinct subtype of undifferentiated pleomorphic sarcoma.” Click to learn more: spkl.io/63327AwdBx
Foundation Medicine will be at #AMPath25 at booth 320! Schedule time to explore solutions that help deliver deeper #genomic insights and more actionable results: spkl.io/63321AwwxT
November 4, 2025 at 3:30 PM
Foundation Medicine will be at #AMPath25 at booth 320! Schedule time to explore solutions that help deliver deeper #genomic insights and more actionable results: spkl.io/63321AwwxT
Honoring #LungCancer Awareness Month this November and all those within our community and beyond who have been impacted by the disease. Follow us this month for patient stories, resources and more.
November 3, 2025 at 2:00 PM
Honoring #LungCancer Awareness Month this November and all those within our community and beyond who have been impacted by the disease. Follow us this month for patient stories, resources and more.
We’re proud to collaborate with Manifold, the AI data platform for life sciences, to bring enhanced analytics capabilities to our FoundationInsights® platform. Learn more: www.foundationmedicine.com/press-releas...
October 30, 2025 at 11:07 AM
We’re proud to collaborate with Manifold, the AI data platform for life sciences, to bring enhanced analytics capabilities to our FoundationInsights® platform. Learn more: www.foundationmedicine.com/press-releas...
Join us at #ISLB25 – November 1-3. Meet our team at booth 201 to learn more about how Foundation Medicine and our FDA-approved #LiquidBiopsy test provides information that can help physicians determine treatment paths for their patients with advanced cancer.
October 23, 2025 at 4:33 PM
Join us at #ISLB25 – November 1-3. Meet our team at booth 201 to learn more about how Foundation Medicine and our FDA-approved #LiquidBiopsy test provides information that can help physicians determine treatment paths for their patients with advanced cancer.
Hear from experts through a series of webinars on the importance of biomarker testing, specifically comprehensive genomic profiling, in #BreastCancer treatment and care. Explore our “Pioneers in Practice – Breast Series” at the link here: spkl.io/63323AXq8Z
Pioneers in Practice - Breast Series
Share your videos with friends, family, and the world
spkl.io
October 22, 2025 at 4:00 PM
Hear from experts through a series of webinars on the importance of biomarker testing, specifically comprehensive genomic profiling, in #BreastCancer treatment and care. Explore our “Pioneers in Practice – Breast Series” at the link here: spkl.io/63323AXq8Z